{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T15:24:08Z","timestamp":1790522648118,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"14","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T00:00:00Z","timestamp":1649808000000},"content-version":"vor","delay-in-days":377,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.jacc.2021.01.052","type":"journal-article","created":{"date-parts":[[2021,4,5]],"date-time":"2021-04-05T18:21:38Z","timestamp":1617646898000},"page":"1731-1743","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Myocardial Angiotensin Metabolism in End-Stage Heart\u00a0Failure"],"prefix":"10.1016","volume":"77","author":[{"given":"Noemi","family":"Pavo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suriya","family":"Prausm\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Spinka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Goliasch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp E.","family":"Bartko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"Wurm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrike","family":"Arfsten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Strunk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marko","family":"Poglitsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Domenig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Mascherbauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keziban","family":"Uyanik-\u00dcnal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Hengstenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Zuckermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"H\u00fclsmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2021.01.052_bib1","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1161\/CIRCRESAHA.116.307708","article-title":"Role of the ACE2\/angiotensin 1-7 axis of the renin-angiotensin system in heart failure","volume":"118","author":"Patel","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2021.01.052_bib2","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nrcardio.2014.59","article-title":"Angiotensin-converting enzyme 2 and angiotensin 1-7: novel therapeutic targets","volume":"11","author":"Jiang","year":"2014","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jacc.2021.01.052_bib3","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00109-008-0336-0","article-title":"Update on tissue renin-angiotensin systems","volume":"86","author":"Bader","year":"2008","journal-title":"J\u00a0Mol Med"},{"key":"10.1016\/j.jacc.2021.01.052_bib4","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.pharmthera.2008.08.009","article-title":"AT2 receptors: functional relevance in cardiovascular disease","volume":"120","author":"Jones","year":"2008","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.jacc.2021.01.052_bib5","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.yjmcc.2009.08.002","article-title":"Intracardiac renin-angiotensin system and myocardial repair\/remodeling following infarction","volume":"48","author":"Sun","year":"2010","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.jacc.2021.01.052_bib6","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.peptides.2013.04.014","article-title":"Angiotensin III: a physiological relevant peptide of the renin angiotensin system","volume":"46","author":"Yugandhar","year":"2013","journal-title":"Peptides"},{"key":"10.1016\/j.jacc.2021.01.052_bib7","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1161\/01.RES.87.5.e1","article-title":"A\u00a0novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9","volume":"87","author":"Donoghue","year":"2000","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2021.01.052_bib8","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1161\/CIRCRESAHA.108.184911","article-title":"Angiotensin(1-7) blunts hypertensive cardiac remodeling by a direct effect on the heart","volume":"103","author":"Mercure","year":"2008","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2021.01.052_bib9","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1093\/eurheartj\/ehs262","article-title":"Neutral endopeptidase inhibition and the natriuretic peptide system: an evolving strategy in cardiovascular therapeutics","volume":"34","author":"Mangiafico","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2021.01.052_bib10","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ejphar.2008.02.090","article-title":"Angiotensin-(1-7): pharmacological properties and pharmacotherapeutic perspectives","volume":"585","author":"Iusuf","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jacc.2021.01.052_bib11","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.jacc.2017.04.025","volume":"70","author":"Yancy","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2021.01.052_bib12","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2021.01.052_bib13","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s40262-013-0072-7","article-title":"Pharmacokinetics and pharmacodynamics of recombinant human angiotensin-converting enzyme 2 in healthy human subjects","volume":"52","author":"Haschke","year":"2013","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jacc.2021.01.052_bib14","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1161\/01.CIR.101.8.844","article-title":"Maximally recommended doses of angiotensin-converting enzyme (ACE) inhibitors do not completely prevent ACE-mediated formation of angiotensin II in chronic heart failure","volume":"101","author":"Jorde","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2021.01.052_bib15","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1056\/NEJMoa1514859","article-title":"Aliskiren, enalapril, or aliskiren and enalapril in\u00a0heart failure","volume":"374","author":"McMurray","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2021.01.052_bib16","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1001\/jama.2013.1954","article-title":"Effect of aliskiren on postdischarge mortality and heart failure readmissions among patients hospitalized for heart failure: the ASTRONAUT randomized trial","volume":"309","author":"Gheorghiade","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2021.01.052_bib17","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1093\/ndt\/gfw071","article-title":"Molecular regulation of the renin-angiotensin system in haemodialysis patients","volume":"31","author":"Kovarik","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jacc.2021.01.052_bib18","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1016\/j.jacc.2016.10.017","article-title":"Renin-angiotensin system fingerprints of heart failure with reduced ejection fraction","volume":"68","author":"Pavo","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2021.01.052_bib19","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.jacc.2016.11.064","article-title":"Roles of angiotensin peptides and recombinant human ACE2 in heart failure","volume":"69","author":"Basu","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2021.01.052_bib20","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1373\/clinchem.2017.278705","article-title":"Low- and high-renin heart failure phenotypes with clinical implications","volume":"64","author":"Pavo","year":"2018","journal-title":"Clin Chem"},{"key":"10.1016\/j.jacc.2021.01.052_bib21","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1016\/j.jacc.2018.08.2186","article-title":"Renal denervation prevents heart failure progression via inhibition of the renin-angiotensin system","volume":"72","author":"Sharp","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2021.01.052_bib22","first-page":"IV7","article-title":"Tissue renin-angiotensin systems. Their role in cardiovascular disease","volume":"87","author":"Lee","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2021.01.052_bib23","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S1357-2725(02)00276-5","article-title":"RAS and connective tissue in the heart","volume":"35","author":"Sun","year":"2003","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.jacc.2021.01.052_bib24","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1001\/archinte.1993.00410080011002","article-title":"Tissue renin-angiotensin system in myocardial hypertrophy and failure","volume":"153","author":"Dzau","year":"1993","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2021.01.052_bib25","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2310\/6650.2007.00020","article-title":"Intracardiac and intrarenal renin-angiotensin systems: mechanisms of cardiovascular and renal effects","volume":"55","author":"Raizada","year":"2007","journal-title":"J\u00a0Investig Med"},{"key":"10.1016\/j.jacc.2021.01.052_bib26","doi-asserted-by":"crossref","first-page":"22D","DOI":"10.1016\/0002-9149(90)90473-E","article-title":"Potential role of the tissue renin-angiotensin system in the pathophysiology of congestive heart failure","volume":"66","author":"Hirsch","year":"1990","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2021.01.052_bib27","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/0002-8703(82)90043-6","article-title":"Determinants of clinical response and survival in patients with congestive heart failure treated\u00a0with captopril","volume":"104","author":"Creager","year":"1982","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2021.01.052_bib28","doi-asserted-by":"crossref","first-page":"H2281","DOI":"10.1152\/ajpheart.00618.2005","article-title":"Advances in biochemical and functional roles of angiotensin-converting enzyme 2 and angiotensin-(1-7) in regulation of cardiovascular function","volume":"289","author":"Ferrario","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jacc.2021.01.052_bib29","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.healun.2016.08.022","article-title":"Effects of angiotensin-converting-enzyme inhibitor therapy on the regulation of the plasma and cardiac tissue renin-angiotensin system in heart transplant patients","volume":"36","author":"Kovarik","year":"2017","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.jacc.2021.01.052_bib30","first-page":"14","article-title":"An update on the tissue renin angiotensin system and its role in physiology and pathology","volume":"6","author":"Nehme","year":"2019","journal-title":"J\u00a0Cardiovasc Dev Dis"},{"key":"10.1016\/j.jacc.2021.01.052_bib31","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s11906-019-0937-8","article-title":"Revisiting the brain renin-angiotensin system-focus on novel therapies","volume":"21","author":"Ren","year":"2019","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.jacc.2021.01.052_bib32","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.yjmcc.2018.12.008","article-title":"Brain renin-angiotensin system blockade with orally active aminopeptidase A inhibitor prevents cardiac dysfunction after myocardial infarction in mice","volume":"127","author":"Boitard","year":"2019","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.jacc.2021.01.052_bib33","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1161\/HYPERTENSIONAHA.116.08922","article-title":"Brain renin-angiotensin system: does it exist?","volume":"69","author":"van Thiel","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2021.01.052_bib34","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2021.01.052_bib35","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1001\/jamacardio.2020.0950","article-title":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China","volume":"5","author":"Shi","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2021.01.052_bib36","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1093\/cvr\/cvaa078","article-title":"The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2","volume":"116","author":"Chen","year":"2020","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacc.2021.01.052_bib37","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nm1267","article-title":"A\u00a0crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury","volume":"11","author":"Kuba","year":"2005","journal-title":"Nat Med"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073510972100379X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073510972100379X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:39:29Z","timestamp":1760017169000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S073510972100379X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":37,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S073510972100379X"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2021.01.052","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Myocardial Angiotensin Metabolism in End-Stage Heart\u00a0Failure","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2021.01.052","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}